Showing results (81-90 of 764) with videos related to
Sort By:
Pageof 77
JAMA Network Open|December 28, 2020
Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the USSamuel L Washington, Chang Wook Jeong, Peter E Lonergan, et al.The Journal of Urology|March 16, 2004
The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registryMatthew R Cooperberg, Jeanette M Broering, Mark S Litwin, et al.The Journal of Urology|May 10, 2005
The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomyMatthew R Cooperberg, David J Pasta, Eric P Elkin, et al.Urology|May 28, 2013
Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA eraAllison S Glass, Janet E Cowan, Mahesh J Fuldeore, et al.The Journal of Urology|April 27, 2019
A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology in Men on Active SurveillanceZachary Kornberg, Matthew R Cooperberg, Janet E Cowan, et al.European Urology|September 6, 2018
Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical ProstatectomyMichael S Leapman, Hao G Nguyen, Janet E Cowan, et al.The Journal of Urology|March 11, 2005
Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSUREJoseph A Mitchell, Matthew R Cooperberg, Eric P Elkin, et al.The Journal of Urology|October 9, 2003
Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURESusan R Harlan, Matthew R Cooperberg, Eric P Elkin, et al.The Journal of Urology|September 5, 2018
Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active SurveillanceZachary Kornberg, Janet E Cowan, Antonio C Westphalen, et al.Cancer|September 8, 2017
The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomyChristopher J Welty, Thomas H Sanford, Jonathan L Wright, et al.Pageof 77